Phase 1/2
Showing 26 - 50 of >10,000
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)
Not yet recruiting
- Facio-Scapulo-Humeral Dystrophy
- ARO-DUX4 for Injection
- Placebo
- (no location specified)
Nov 13, 2023
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)
Not yet recruiting
- Anaphylactic Reaction
- Epinephrine
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 22, 2023
Solid Tumor Trial in Sydney (IBI129)
Not yet recruiting
- Solid Tumor
-
Sydney, New South Wales, AustriaSt George private Hospital
Aug 6, 2023
NSCLC Trial (Dupilumab, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Dupilumab
- Cemiplimab
- (no location specified)
Oct 12, 2023
Advanced Solid Tumor Trial (7MW3711 for injection)
Not yet recruiting
- Advanced Solid Tumor
- 7MW3711 for injection
- (no location specified)
Aug 18, 2023
Pancreatic Cancer Trial (PBP1510 (400mg/16mL), Gemcitabine (1000 mg/m^2))
Not yet recruiting
- Pancreatic Cancer
- PBP1510 (400mg/16mL)
- Gemcitabine (1000 mg/m^2)
- (no location specified)
Sep 27, 2022
COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)
Active, not recruiting
- COVID-19
- +2 more
- VB10.2129
- VB10.2210
-
Bergen, Norway
- +1 more
Jan 6, 2023
Advanced Gastrointestinal Tumors Trial in Shanghai (Donafenib Tosilate Tablets, KN046 Injection)
Recruiting
- Advanced Gastrointestinal Tumors
- Donafenib Tosilate Tablets
- KN046 Injection
-
Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Nov 28, 2022
Advanced Prostate Cancer Trial (HRS-4357 injection)
Not yet recruiting
- Advanced Prostate Cancer
- HRS-4357 injection
- (no location specified)
Aug 16, 2023
Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)
Recruiting
- Advanced Solid Tumor
- YL201 for Injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 21, 2023
Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- (no location specified)
Mar 21, 2023
Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- (no location specified)
Jun 15, 2023
Advanced Solid Tumor Trial in Brussels (GTAEXS617)
Recruiting
- Advanced Solid Tumor
-
Brussels, BelgiumClinique Universitaires Saint-Luc
Aug 8, 2023
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Melanoma Metastatic in the Brain Trial in Gainesville (CA-4948, Pembrolizumab)
Not yet recruiting
- Melanoma Metastatic in the Brain
-
Gainesville, FloridaUniversity of Florida
Dec 20, 2022